Back to Browse Journals » Patient Preference and Adherence » Volume 2

Adherence in Internet-based interventions

Authors Silje C Wangberg, Trine S Bergmo, Jan-Are K Johnsen

Published Date March 2008 Volume 2008:2 Pages 57—65

DOI http://dx.doi.org/

Published 11 March 2008

Silje C Wangberg, Trine S Bergmo, Jan-Are K Johnsen

Norwegian Centre for Telemedicine, University Hospital of North Norway, Tromsø, Norway

Background: The Internet is a promising channel for delivering health-promoting interventions. A common problem for Internet-based interventions is low adherence. The current paper reports adherence rates from three different Internet-based trials with potential covariates.

Methods: Data on adherence and baseline characteristics of users were collected from three different Internet-based trials: one supporting diabetes self-management, one supporting smoking cessation, and one offering an online personal health record. Logging of web use was used as the measure of adherence in two of the trials, while logging of authentication SMS messages was used in the third.

Results: In all three trials, users dropped out at a high rate early in the intervention. The baseline variables that were related to use were self-efficacy, having smoking friends, age, gender, and education. Tailored emails increased use for up to five months into a one-year intervention.

Conclusion: Dropout from Internet-based trials is substantial, and attrition curves can be a valuable tool for more accurate pretrial estimates of sample size power. Automated follow-up of users via email seems likely to increase adherence and should be included in Internet-based interventions. Tailoring on baseline covariates to adherence such as self-efficacy could make them even more effective.

Keywords: Internet-based interventions, adherence, attrition, tailoring, self-efficacy

Download Article [PDF] 

Readers of this article also read:

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

Kim JY, Lee SH, Park CW, Rhee YS, Kim DW, Park J, Lee M, Seo JW, Park ES

Drug Design, Development and Therapy 2015, 9:695-706

Published Date: 30 January 2015

Progressive osseous heteroplasia: diagnosis, treatment, and prognosis

Pignolo RJ, Ramaswamy G, Fong JT, Shore EM, Kaplan FS

The Application of Clinical Genetics 2015, 8:37-48

Published Date: 30 January 2015

Gastrointestinal robotic surgery: challenges and developments

Bencini L, Annecchiarico M, Di Marino M, Moraldi L, Perna F, Coratti A

Robotic Surgery: Research and Reviews 2015, 2:11-27

Published Date: 30 January 2015

Diabetes reversal via gene transfer: building on successes in animal models

Gerace D, Martiniello-Wilks R, Simpson AM

Research and Reports in Endocrine Disorders 2015, 5:15-29

Published Date: 29 January 2015

Corneal laceration caused by river crab

Vinuthinee N, Azreen-Redzal A, Juanarita J, Zunaina E

Clinical Ophthalmology 2015, 9:203-206

Published Date: 29 January 2015

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]

Tsumura T, Yoshikawa K, Suzumura H, Kimura T, Sasaki S, Kimura I, Takeda R

Clinical Ophthalmology 2013, 7:129-130

Published Date: 16 January 2013

Blood–brain barrier: a real obstacle for therapeutics

Shiekh FA

International Journal of Nanomedicine 2012, 7:4065-4067

Published Date: 27 July 2012

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011